Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 6.66 | (454.11) | (372.26)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 0.25 | (527.20) | (408.64)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Viking Therapeutics soars 120% following positiv... | 18-Sep-2018 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 28.75 |
| Change Today | $ -0.55 |
| % Change | -1.88 % |
| 52 Week High | $40.94 |
| 52 Week Low | $21.28 |
| Volume | 1,921,547 |
| Shares Issued | 72.03m |
| Market Cap | $2,070.80m |
| RiskGrade | 326 |
| Strong Buy | 8 |
| Buy | 9 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 18 |

| Time | Volume / Share Price |
| 16:00 | 114,565 @ $28.75 |
| 15:59 | 100 @ $28.76 |
| 15:59 | 100 @ $28.75 |
| 15:59 | 300 @ $28.75 |
| 15:59 | 100 @ $28.75 |
You are here: research